Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diphenhydramine versus dexmedetomidine-based sedation for fiberoptic bronchoscopy
IRCT20130304012695N18Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of diphenhydramine, dexmedetomidine and propofol in None (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Degree of sedation, Propofol rescue requirement and 6 more. Started Dec 2023; status: completed.
02
Drugs
diphenhydraminedexmedetomidinepropofol
Beyond the preview
Go deeper on IRCT20130304012695N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130304012695N18.